United States Biotechnology & Medical Research

Medivation Inc (MDVN)

Track

Ticker: MDVN Exchange: NSQ
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Planned sale 6 Jun 2016
Value US$2,576,373.95 | Price 182.71 | Shares 52,299 (-45.1%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2016-06-06 2016-06-06 PlS Planned sale Powell Andrew Kenneth William

SVP, General Counsel & Crp Sec

Officer
52,299 -45.1%
182.71
US$2,576,374 		52,299 -45.1% 182.71 US$2,576,374
2016-05-09 2016-05-06 PlS Planned sale Bierly Rick

CFO (former)

Officer
80,963 +30.8%
477.56
US$1,527,722 		80,963 +30.8% 477.56 US$1,527,722
2016-05-09 2016-05-06 PlS Planned sale Bierly Rick

CFO (former)

Officer
23,287 +2.0%
74.28
US$3,309,842 		23,287 +2.0% 74.28 US$3,309,842
2016-05-09 2016-05-05 S Sale Bierly Rick

CFO (former)

Officer
4,025 -10.3%
59.20
US$238,280 		4,025 -10.3% 59.20 US$238,280
2016-03-16 2016-03-14 S Sale Svoronos Dawn Non-Executive Director
6,000 -24.8%
38.90
US$233,400 		6,000 -24.8% 38.90 US$233,400
2016-03-07 2016-03-04 PlS Planned sale Bierly Rick

Chief Financial Officer

Officer
1,875 -4.6%
40.00
US$75,000 		1,875 -4.6% 40.00 US$75,000
2016-03-07 2016-03-04 S Sale Bierly Rick

Chief Financial Officer

Officer
1,123 -2.7%
40.00
US$44,920 		1,123 -2.7% 40.00 US$44,920
2016-03-07 2016-03-04 S Sale Hirmand Mohammad

Interim Chief Medical Officer

Officer
1,525 -3.7%
41.10
US$62,685 		1,525 -3.7% 41.10 US$62,685
2016-03-07 2016-03-04 S Sale Hung David

President and CEO

Executive Director
5,085 -0.3%
41.10
US$208,994 		5,085 -0.3% 41.10 US$208,994
2016-02-05 2016-02-04 S Sale Hung David

President and CEO

Executive Director
6,350 -0.4%
31.18
US$197,993 		6,350 -0.4% 31.18 US$197,993
2016-01-21 2016-01-19 PlS Planned sale Machado Clarence Patrick Non-Executive Director
6,950 -9.5%
39.19
US$272,370 		6,950 -9.5% 39.19 US$272,370
2016-01-21 2016-01-19 PlS Planned sale Machado Clarence Patrick Non-Executive Director
7,942 -9.8%
38.62
US$306,720 		7,942 -9.8% 38.62 US$306,720
2016-01-21 2016-01-19 PlS Planned sale Machado Clarence Patrick Non-Executive Director
23,087 -22.2%
37.50
US$865,762 		23,087 -22.2% 37.50 US$865,762
2016-01-21 2016-01-19 PlS Planned sale Machado Clarence Patrick Non-Executive Director
37,021 -26.2%
36.62
US$1,355,709 		37,021 -26.2% 36.62 US$1,355,709
2016-01-05 2016-01-04 S Sale Lobacki Joseph M

Chief Commercial Officer

Officer
3,065 -13.7%
46.50
US$142,522 		3,065 -13.7% 46.50 US$142,522
2015-12-16 2015-12-14 B Purchase VERNON W ANTHONY Non-Executive Director
15,000 +109.5%
40.69
US$610,350 		15,000 +109.5% 40.69 US$610,350
2015-09-28 2015-09-25 PlS Planned sale Machado Clarence Patrick Non-Executive Director
17,680 -21.1%
43.92
US$776,506 		17,680 -21.1% 43.92 US$776,506
2015-09-28 2015-09-25 PlS Planned sale Machado Clarence Patrick Non-Executive Director
20,464 -19.6%
42.68
US$873,404 		20,464 -19.6% 42.68 US$873,404
2015-09-28 2015-09-25 PlS Planned sale Machado Clarence Patrick Non-Executive Director
22,236 -17.6%
41.63
US$925,685 		22,236 -17.6% 41.63 US$925,685
2015-09-28 2015-09-25 PlS Planned sale Machado Clarence Patrick Non-Executive Director
11,600 -8.5%
40.82
US$473,512 		11,600 -8.5% 40.82 US$473,512
2015-06-08 2015-06-04 PlS Planned sale Machado Clarence Patrick Non-Executive Director
300 -0.9%
120.04
US$36,012 		300 -0.9% 120.04 US$36,012
2015-06-08 2015-06-04 PlS Planned sale Machado Clarence Patrick Non-Executive Director
9,600 -23.2%
119.06
US$1,142,976 		9,600 -23.2% 119.06 US$1,142,976
2015-06-08 2015-06-04 PlS Planned sale Machado Clarence Patrick Non-Executive Director
6,600 -13.8%
118.38
US$781,308 		6,600 -13.8% 118.38 US$781,308
2015-06-08 2015-06-04 PlS Planned sale Machado Clarence Patrick Non-Executive Director
2,900 -5.7%
117.10
US$339,590 		2,900 -5.7% 117.10 US$339,590
2015-06-08 2015-06-04 PlS Planned sale Machado Clarence Patrick Non-Executive Director
16,600 -24.6%
116.12
US$1,927,592 		16,600 -24.6% 116.12 US$1,927,592
2015-05-06 2015-05-05 PlS Planned sale Bierly Rick

Chief Financial Officer

Officer
1,615 -9.1%
125.00
US$201,875 		1,615 -9.1% 125.00 US$201,875
2015-04-16 2015-04-15 PlS Planned sale Bierly Rick

Chief Financial Officer

Officer
3,000 -13.0%
132.20
US$396,600 		3,000 -13.0% 132.20 US$396,600
2015-03-17 2015-03-16 S Sale Rhodes Jennifer J

GC & Corporate Secretary

Officer
1,390 -11.1%
130.92
US$181,979 		1,390 -11.1% 130.92 US$181,979
2015-03-04 2015-03-02 S Sale Svoronos Dawn Non-Executive Director
3,350 -19.7%
119.75
US$401,163 		3,350 -19.7% 119.75 US$401,163
2015-03-02 2015-03-02 PlS Planned sale Hung David

President and CEO

Executive Director
32,191 -4.1%
121.49
US$3,910,885 		32,191 -4.1% 121.49 US$3,910,885
2015-03-02 2015-03-02 PlS Planned sale Rhodes Jennifer J

GC & Corporate Secretary

Officer
2,000 -13.8%
122.00
US$244,000 		2,000 -13.8% 122.00 US$244,000
2015-03-02 2015-02-27 B Purchase FALBERG KATHRYN E Non-Executive Director
800 +3.3%
119.11
US$95,288 		800 +3.3% 119.11 US$95,288
2015-03-02 2015-02-27 B Purchase FALBERG KATHRYN E Non-Executive Director
1,400 +6.1%
118.37
US$165,718 		1,400 +6.1% 118.37 US$165,718
2015-03-02 2015-02-27 B Purchase FALBERG KATHRYN E Non-Executive Director
19,400 +570.6%
117.76
US$2,284,544 		19,400 +570.6% 117.76 US$2,284,544
2015-03-02 2015-02-27 B Purchase FALBERG KATHRYN E Non-Executive Director
3,400 +inf%
116.51
US$396,134 		3,400 +inf% 116.51 US$396,134
2015-02-27 2015-02-26 PlS Planned sale Rhodes Jennifer J

GC & Corporate Secretary

Officer
2,000 -14.9%
120.00
US$240,000 		2,000 -14.9% 120.00 US$240,000
2015-02-27 2015-02-26 PlS Planned sale Rhodes Jennifer J

GC & Corporate Secretary

Officer
1,089 -7.5%
118.00
US$128,502 		1,089 -7.5% 118.00 US$128,502
2015-02-12 2015-02-10 PlS Planned sale Machado Clarence Patrick Non-Executive Director
20,700 -39.7%
104.35
US$2,160,045 		20,700 -39.7% 104.35 US$2,160,045
2015-02-12 2015-02-10 PlS Planned sale Machado Clarence Patrick Non-Executive Director
11,200 -17.7%
103.66
US$1,160,992 		11,200 -17.7% 103.66 US$1,160,992
2015-02-12 2015-02-10 PlS Planned sale Machado Clarence Patrick Non-Executive Director
3,400 -5.1%
102.37
US$348,058 		3,400 -5.1% 102.37 US$348,058
2015-02-12 2015-02-10 PlS Planned sale Machado Clarence Patrick Non-Executive Director
700 -1.0%
101.27
US$70,889 		700 -1.0% 101.27 US$70,889
2015-01-29 2015-01-27 PlS Planned sale Machado Clarence Patrick Non-Executive Director
18,800 -37.4%
105.67
US$1,986,596 		18,800 -37.4% 105.67 US$1,986,596
2015-01-29 2015-01-27 PlS Planned sale Machado Clarence Patrick Non-Executive Director
17,200 -25.5%
104.93
US$1,804,796 		17,200 -25.5% 104.93 US$1,804,796
2015-01-22 2015-01-20 PlS Planned sale Hung David

President and CEO

Executive Director
14,900 -1.7%
109.17
US$1,626,633 		14,900 -1.7% 109.17 US$1,626,633
2015-01-22 2015-01-20 PlS Planned sale Hung David

President and CEO

Executive Director
64,234 -6.8%
108.09
US$6,943,053 		64,234 -6.8% 108.09 US$6,943,053
2014-10-23 2014-10-22 PlS Planned sale Seely Lynn

Chief Medical Officer

Officer
5,000 -7.7%
99.03
US$495,142 		5,000 -7.7% 99.03 US$495,142
2014-10-17 2014-10-16 PlS Planned sale Seely Lynn

Chief Medical Officer

Officer
5,000 -7.7%
93.97
US$469,850 		5,000 -7.7% 93.97 US$469,850
2014-10-17 2014-10-15 PlS Planned sale Seely Lynn

Chief Medical Officer

Officer
100 -0.2%
90.41
US$9,041 		100 -0.2% 90.41 US$9,041
2014-10-17 2014-10-15 PlS Planned sale Seely Lynn

Chief Medical Officer

Officer
8,946 -13.0%
89.82
US$803,530 		8,946 -13.0% 89.82 US$803,530
2014-10-17 2014-10-15 PlS Planned sale Seely Lynn

Chief Medical Officer

Officer
12,300 -15.1%
88.94
US$1,093,962 		12,300 -15.1% 88.94 US$1,093,962
2014-10-17 2014-10-15 PlS Planned sale Seely Lynn

Chief Medical Officer

Officer
3,000 -3.6%
87.61
US$262,830 		3,000 -3.6% 87.61 US$262,830
2014-09-18 2014-09-18 PlS Planned sale Seely Lynn

Chief Medical Officer

Officer
7,200 -10.9%
100.44
US$723,168 		7,200 -10.9% 100.44 US$723,168
2014-09-18 2014-09-18 PlS Planned sale Seely Lynn

Chief Medical Officer

Officer
17,800 -21.2%
99.55
US$1,771,990 		17,800 -21.2% 99.55 US$1,771,990
2014-09-18 2014-09-17 PlS Planned sale Seely Lynn

Chief Medical Officer

Officer
3,400 -5.4%
98.16
US$333,744 		3,400 -5.4% 98.16 US$333,744
2014-09-18 2014-09-17 PlS Planned sale Seely Lynn

Chief Medical Officer

Officer
13,300 -17.6%
97.66
US$1,298,878 		13,300 -17.6% 97.66 US$1,298,878
2014-09-18 2014-09-17 PlS Planned sale Seely Lynn

Chief Medical Officer

Officer
13,300 -14.9%
96.85
US$1,288,105 		13,300 -14.9% 96.85 US$1,288,105
2014-09-11 2014-09-09 PlS Planned sale Seely Lynn

Chief Medical Officer

Officer
5,187 -8.1%
95.06
US$493,076 		5,187 -8.1% 95.06 US$493,076
2014-09-11 2014-09-09 PlS Planned sale Seely Lynn

Chief Medical Officer

Officer
14,813 -18.7%
94.44
US$1,398,940 		14,813 -18.7% 94.44 US$1,398,940
2014-08-28 2014-08-27 PlS Planned sale Seely Lynn

Chief Medical Officer

Officer
2,600 -4.2%
90.42
US$235,092 		2,600 -4.2% 90.42 US$235,092
2014-08-28 2014-08-27 PlS Planned sale Seely Lynn

Chief Medical Officer

Officer
11,700 -16.0%
89.43
US$1,046,331 		11,700 -16.0% 89.43 US$1,046,331
2014-08-28 2014-08-26 PlS Planned sale Seely Lynn

Chief Medical Officer

Officer
5,700 -8.8%
88.95
US$507,032 		5,700 -8.8% 88.95 US$507,032
2014-08-14 2014-08-13 PlS Planned sale Seely Lynn

Chief Medical Officer

Officer
3,300 -5.3%
84.63
US$279,279 		3,300 -5.3% 84.63 US$279,279
2014-08-14 2014-08-13 PlS Planned sale Seely Lynn

Chief Medical Officer

Officer
5,700 -8.4%
84.01
US$478,857 		5,700 -8.4% 84.01 US$478,857
2014-08-14 2014-08-13 PlS Planned sale Seely Lynn

Chief Medical Officer

Officer
11,000 -13.9%
83.12
US$914,320 		11,000 -13.9% 83.12 US$914,320
2014-08-12 2014-08-12 PlS Planned sale Seely Lynn

Chief Medical Officer

Officer
12,500 -17.5%
84.01
US$1,050,125 		12,500 -17.5% 84.01 US$1,050,125
2014-08-12 2014-08-08 PlS Planned sale Seely Lynn

Chief Medical Officer

Officer
3,300 -5.3%
83.90
US$276,870 		3,300 -5.3% 83.90 US$276,870
2014-08-12 2014-08-08 PlS Planned sale Seely Lynn

Chief Medical Officer

Officer
2,500 -3.9%
82.40
US$206,000 		2,500 -3.9% 82.40 US$206,000
2014-08-12 2014-08-08 PlS Planned sale Seely Lynn

Chief Medical Officer

Officer
2,900 -4.3%
81.60
US$236,640 		2,900 -4.3% 81.60 US$236,640
2014-08-12 2014-08-08 PlS Planned sale Seely Lynn

Chief Medical Officer

Officer
4,300 -6.0%
80.77
US$347,311 		4,300 -6.0% 80.77 US$347,311
2014-07-23 2014-07-22 PlS Planned sale Seely Lynn

Chief Medical Officer

Officer
7,500 -11.3%
73.96
US$554,710 		7,500 -11.3% 73.96 US$554,710
2014-07-07 2014-07-02 PlS Planned sale Seely Lynn

Chief Medical Officer

Officer
12,000 -16.9%
79.02
US$948,194 		12,000 -16.9% 79.02 US$948,194
2014-06-19 2014-06-18 PlS Planned sale Seely Lynn

Chief Medical Officer

Officer
2,000 -3.3%
75.51
US$151,020 		2,000 -3.3% 75.51 US$151,020
2014-06-19 2014-06-18 PlS Planned sale Seely Lynn

Chief Medical Officer

Officer
5,500 -8.3%
74.82
US$411,510 		5,500 -8.3% 74.82 US$411,510
2014-06-19 2014-06-03 PlS Planned sale Seely Lynn

Chief Medical Officer

Officer
1,000 -1.7%
75.03
US$75,030 		1,000 -1.7% 75.03 US$75,030
2014-06-19 2014-06-03 PlS Planned sale Seely Lynn

Chief Medical Officer

Officer
6,500 -9.8%
74.42
US$483,730 		6,500 -9.8% 74.42 US$483,730
Explore more

More insider trading research around Medivation Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America